Latest news about AscellaHealth
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
AscellaHealth released its Q4 2024 Specialty & Rare Pipeline Digest, highlighting sustained growth in specialty drug approvals and biosimilar launches, and noting increased demand for novel therapies for rare and complex conditions[1].Additionally, AscellaHealth announced the expansion of its Optime Care specialty pharmacy with a new location at its Berwyn, PA headquarters, enhancing its ability to manage specialty patient populations and deliver patient support programs[4].
AscellaHealth will showcase its end-to-end specialty pharmaceutical commercialization solutions as a Gold Sponsor at the World Orphan Drug Congress Europe in Barcelona, Spain, from October 22-25, 2024. The company will exhibit its innovative services to streamline commercialization, support access, and improve patient outcomes for rare and orphan diseases[5].
AscellaHealth announced a strategic global joint venture with 4Merit Connections, a dedicated provider of outsourced services to the UK government, to deliver comprehensive healthcare solutions to governments and public organizations worldwide, leveraging their combined strengths in healthcare and pharmaceutical services[5].
Open job positions at AscellaHealth
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

